| Synthesis and characterization of novel inorganic/organometallic compounds | Lifetime | 1 | GB 1 | 99.93 |
| Smoking Behavior and Cessation | Lifetime | 2 | GB 1 | 99.89 |
| Silicone and Siloxane Chemistry | Lifetime | 2 | GB 1 | 99.90 |
| Inorganic and Organometallic Chemistry | Lifetime | 5 | GB 1 | 99.93 |
| Behavioral Health and Interventions | Lifetime | 5 | GB 2 | 99.91 |
| School Health and Nursing Education | Lifetime | 2 | GB 1 | 99.74 |
| Organoboron and organosilicon chemistry | Lifetime | 7 | GB 1 | 99.83 |
| Obesity, Physical Activity, Diet | Lifetime | 57 | GB 8 | 99.79 |
| Coordination Chemistry and Organometallics | Lifetime | 19 | GB 2 | 99.68 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 13 | GB 6 | 99.42 |
| Nicotinic Acetylcholine Receptors Study | Lifetime | 38 | GB 2 | 99.30 |
| Health Policy Implementation Science | Lifetime | 41 | GB 8 | 99.20 |
| Organometallic Complex Synthesis and Catalysis | Lifetime | 108 | GB 12 | 99.46 |
| Mobile Health and mHealth Applications | Lifetime | 120 | GB 17 | 98.45 |
| Global Public Health Policies and Epidemiology | Lifetime | 110 | GB 19 | 98.45 |
| Chemical Reactions and Mechanisms | Lifetime | 78 | GB 3 | 98.22 |
| Organic Chemistry Cycloaddition Reactions | Lifetime | 159 | GB 7 | 98.39 |
| Chemical Synthesis and Reactions | Lifetime | 374 | GB 20 | 98.43 |
| Molecular Junctions and Nanostructures | Lifetime | 441 | GB 23 | 98.69 |
| Cyclopropane Reaction Mechanisms | Lifetime | 188 | GB 6 | 98.68 |
| Oxidative Organic Chemistry Reactions | Lifetime | 329 | GB 17 | 98.48 |
| Radical Photochemical Reactions | Lifetime | 220 | GB 10 | 98.08 |
| Traffic and Road Safety | Lifetime | 200 | GB 11 | 98.14 |
| Asymmetric Synthesis and Catalysis | Lifetime | 406 | GB 26 | 98.75 |
| Health disparities and outcomes | Lifetime | 452 | GB 87 | 98.21 |
| Digital Mental Health Interventions | Lifetime | 157 | GB 22 | 97.86 |
| Various Chemistry Research Topics | Lifetime | 178 | GB 13 | 97.88 |
| COVID-19 and Mental Health | Lifetime | 488 | GB 75 | 96.60 |
| Hermeneutics and Narrative Identity | Lifetime | 326 | GB 59 | 93.50 |
| Synthesis and Reactivity of Heterocycles | Lifetime | 140 | GB 9 | 96.69 |
| Health, psychology, and well-being | Lifetime | 176 | GB 41 | 97.48 |
| Synthetic Organic Chemistry Methods | Lifetime | 606 | GB 29 | 98.31 |
| Synthesis and Biological Evaluation | Lifetime | 642 | GB 35 | 96.89 |
| Community Health and Development | Lifetime | 137 | GB 8 | 97.28 |
| Mesoporous Materials and Catalysis | Lifetime | 406 | GB 14 | 97.74 |
| Synthesis and Properties of Aromatic Compounds | Lifetime | 216 | GB 8 | 97.29 |
| Fluorine in Organic Chemistry | Lifetime | 559 | GB 43 | 97.09 |
| Muon and positron interactions and applications | Lifetime | 247 | GB 18 | 95.31 |
| Structural and Chemical Analysis of Organic and Inorganic Compounds | Lifetime | 174 | GB 11 | 96.32 |
| Substance Abuse Treatment and Outcomes | Lifetime | 480 | GB 36 | 97.19 |
| Photochemistry and Electron Transfer Studies | Lifetime | 937 | GB 65 | 96.65 |
| Crystallography and molecular interactions | Lifetime | 639 | GB 81 | 96.07 |
| Synthesis and properties of polymers | Lifetime | 948 | GB 35 | 95.23 |
| History and advancements in chemistry | Lifetime | 299 | GB 20 | 94.08 |
| Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes | Lifetime | 976 | GB 100 | 95.16 |
| Opioid Use Disorder Treatment | Lifetime | 813 | GB 47 | 93.49 |
| Consumer Attitudes and Food Labeling | Lifetime | 635 | GB 67 | 92.71 |
| Organometallic Compounds Synthesis and Characterization | Lifetime | 773 | GB 77 | 93.40 |
| Media Influence and Health | Lifetime | 371 | GB 20 | 92.95 |
| Obesity and Health Practices | Lifetime | 890 | GB 116 | 92.51 |
| Meta-analysis and systematic reviews | Lifetime | 752 | GB 157 | 91.93 |
| Academic Writing and Publishing | Lifetime | 81 | GB 11 | 87.87 |
| Health Literacy and Information Accessibility | Lifetime | 768 | GB 59 | 89.81 |
| N-Heterocyclic Carbenes in Organic and Inorganic Chemistry | Lifetime | 586 | GB 39 | 90.19 |
| Forensic Toxicology and Drug Analysis | Lifetime | 905 | GB 63 | 90.09 |
| Healthcare Systems and Challenges | Lifetime | 282 | GB 123 | 81.47 |
| Older Adults Driving Studies | Lifetime | 481 | GB 25 | 84.35 |
| Pharmaceutical industry and healthcare | Lifetime | 966 | GB 92 | 78.44 |
| Shakespeare, Adaptation, and Literary Criticism | Lifetime | 971 | GB 198 | 72.69 |
| Health Services Management and Policy | Lifetime | 359 | GB 148 | 73.11 |
| Crime, Deviance, and Social Control | Lifetime | 644 | GB 128 | 58.28 |
| Behavioral Health and Interventions | 2021-2025 | 137 | GB 20 | 95.57 |
| Smoking Behavior and Cessation | 2021-2025 | 239 | GB 27 | 93.11 |
| Community Health and Development | 2021-2025 | 853 | GB 102 | 58.82 |
| Healthcare Systems and Challenges | 2021-2025 | 253 | GB 108 | 44.81 |
| Wikis in Education and Collaboration | 2021-2025 | 201 | GB 11 | 32.09 |
